Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the rando...

por Lugtenburg, Pieternella, Avivi, Irit, Berenschot, Henriette, Ilhan, Osman, Marolleau, Jean Pierre, Nagler, Arnon, Rueda, Antonio, Tani, Monica, Turgut, Mehmet, Osborne, Stuart, Smith, Rodney, Pfreundschuh, Michael
Publicado 2017

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial

por Scarfò, Lydia, Ferrari, Silvia, Frustaci, Anna Maria, Tani, Monica, Bari, Alessia, Scarano, Eloise, Colia, Maria, Ranghetti, Pamela, Angelillo, Piera, Ronchi, Paola, Ponzoni, Maurilio, Ferreri, Andrés J. M., Ghia, Paolo
Publicado 2022

Lenalidomide in Combination with Dexamethasone in Elderly Patients with Advanced, Relapsed or Refractory Multiple Myeloma and Renal Failure

por Tosi, Patrizia, Gamberi, Barbara, Castagnari, Barbara, Molinari, Anna Lia, Savini, Paolo, Ceccolini, Michela, Tani, Monica, Merli, Anna, Imola, Manuela, Mianulli, Anna Maria, Cellini, Claudia, Tomassetti, Simona, Merli, Francesco, Fattori, Pierpaolo, Zaccaria, Alfonso
Publicado 2013

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma

por Younes, Anas, Burke, John M., Diefenbach, Catherine, Ferrari, Silvia, Khan, Cyrus, Sharman, Jeff P., Tani, Monica, Ujjani, Chaitra, Vitolo, Umberto, Yuen, Sam, Raval, Aparna, Shivhare, Mahesh, Nielsen, Tina G., Sellam, Gila, Gilbertson, Michael
Publicado 2022

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

por Ballotta, Laura, Zinzani, Pier Luigi, Pileri, Stefano, Bruna, Riccardo, Tani, Monica, Casadei, Beatrice, Tabanelli, Valentina, Volpetti, Stefano, Luminari, Stefano, Corradini, Paolo, Lucchini, Elisa, Tisi, Maria Chiara, Merli, Michele, Re, Alessandro, Varettoni, Marzia, Pesce, Emanuela Anna, Zaja, Francesco
Publicado 2021

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

por Younes, Anas, Burke, John M., Cheson, Bruce D., Diefenbach, Catherine S., Ferrari, Silvia, Hahn, Uwe H., Hawkes, Eliza A., Khan, Cyrus, Lossos, Izidore S., Musuraca, Gerardo, Tani, Monica, Vitolo, Umberto, Yuen, Sam, Raval, Aparna, Shivhare, Mahesh, Nielsen, Tina G., Sellam, Gila, Sharman, Jeff P.
Publicado 2022

P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): EXTENDED FOLLOW-UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY

por Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Dickinson, Michael, Bachy, Emmanuel, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquín, Bartlett, Nancy L., Salar, Antonio, Brody, Joshua, Leppa, Sirpa, Baumlin, Pauline, Lundberg, Linda, Relf, James, Xie, Yuying, Bottos, Alessia, Humphrey, Kathryn, Falchi, Lorenzo
Publicado 2023

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

por Musuraca, Gerardo, De Matteis, Serena, Napolitano, Roberta, Papayannidis, Cristina, Guadagnuolo, Viviana, Fabbri, Francesco, Cangini, Delia, Ceccolini, Michela, Giannini, Maria Benedetta, Lucchesi, Alessandro, Ronconi, Sonia, Mariotti, Paolo, Savini, Paolo, Tani, Monica, Fattori, Pier Paolo, Guidoboni, Massimo, Martinelli, Giovanni, Zoli, Wainer, Amadori, Dino, Carloni, Silvia
Publicado 2015

The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments

por Bari, Alessia, Marcheselli, Raffaella, Sacchi, Stefano, Re, Alessandro, Pagani, Chiara, Tucci, Alessandra, Botto, Barbara, Vitolo, Umberto, Molinari, Anna Lia, Puccini, Benedetta, Pulsoni, Alessandro, Santoro, Armando, Tani, Monica, Nassi, Luca, Meli, Erika, Pavone, Vincenzo, Bonfichi, Maurizio, Evangelista, Andrea, Gioia, Daniela, Levis, Alessandro, Zinzani, Pierluigi
Publicado 2019

Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study

por Casadei, Beatrice, Argnani, Lisa, Broccoli, Alessandro, Patti, Caterina, Stefani, Piero Maria, Cuneo, Antonio, Margiotta Casaluci, Gloria, Visco, Carlo, Gini, Guido, Pane, Fabrizio, D’Alò, Francesco, Luzi, Debora, Cantonetti, Maria, Pozzi, Samantha, Musuraca, Gerardo, Rosignoli, Chiara, Arcari, Annalisa, Kovalchuk, Sofya, Tani, Monica, Tisi, Maria Chiara, Petrini, Mario, Stefoni, Vittorio, Zinzani, Pier Luigi
Publicado 2022

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondaz...

por Storti, Sergio, Spina, Michele, Pesce, Emanuela Anna, Salvi, Flavia, Merli, Michele, Ruffini, Alessia, Cabras, Giuseppina, Chiappella, Annalisa, Angelucci, Emanuele, Fabbri, Alberto, Liberati, Anna Marina, Tani, Monica, Musuraca, Gerardo, Molinari, Annalia, Petrilli, Maria Pia, Palladino, Carmela, Ciancia, Rosanna, Ferrario, Andrea, Gasbarrino, Cristiana, Monaco, Federico, Fraticelli, Vincenzo, De Vellis, Annalisa, Merli, Francesco, Luminari, Stefano
Publicado 2018

Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion

por Tam, Constantine S., Robak, Tadeusz, Ghia, Paolo, Kahl, Brad S., Walker, Patricia, Janowski, Wojciech, Simpson, David, Shadman, Mazyar, Ganly, Peter S., Laurenti, Luca, Opat, Stephen, Tani, Monica, Ciepluch, Hanna, Verner, Emma, Šimkovič, Martin, Österborg, Anders, Trněný, Marek, Tedeschi, Alessandra, Paik, Jason C., Kuwahara, Sowmya B., Feng, Shibao, Ramakrishnan, Vanitha, Cohen, Aileen, Huang, Jane, Hillmen, Peter, Brown, Jennifer R.
Publicado 2020

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL

por Tisi, Maria Chiara, Moia, Riccardo, Patti, Caterina, Evangelista, Andrea, Ferrero, Simone, Spina, Michele, Tani, Monica, Botto, Barbara, Celli, Melania, Puccini, Benedetta, Cencini, Emanuele, Di Rocco, Alice, Chini, Claudio, Ghiggi, Chiara, Zambello, Renato, Zanni, Manuela, Sciarra, Roberta, Bruna, Riccardo, Ferrante, Martina, Pileri, Stefano Alessandro, Quaglia, Francesca Maria, Stelitano, Caterina, Re, Alessandro, Volpetti, Stefano, Zilioli, Vittorio Ruggero, Arcari, Annalisa, Merli, Francesco, Visco, Carlo
Publicado 2023

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

por Nowakowski, Grzegorz S., Chiappella, Annalisa, Gascoyne, Randy D., Scott, David W., Zhang, Qingyuan, Jurczak, Wojciech, Özcan, Muhit, Hong, Xiaonan, Zhu, Jun, Jin, Jie, Belada, David, Bergua, Juan Miguel, Piazza, Francesco, Mócikova, Heidi, Molinari, Anna Lia, Yoon, Dok Hyun, Cavallo, Federica, Tani, Monica, Yamamoto, Kazuhito, Izutsu, Koji, Kato, Koji, Czuczman, Myron, Hersey, Sarah, Kilcoyne, Adrian, Russo, Jacqueline, Hudak, Krista, Zhang, Jingshan, Wade, Steve, Witzig, Thomas E., Vitolo, Umberto
Publicado 2021

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial

por Ricardi, Umberto, Levis, Mario, Evangelista, Andrea, Gioia, Daniela Maria, Sacchetti, Gian Mauro, Gotti, Manuel, Re, Alessandro, Buglione, Michela, Pavone, Vincenzo, Nardella, Antonio, Nassi, Luca, Zanni, Manuela, Franzone, Paola, Frezza, Giovanni Piero, Pulsoni, Alessandro, Grapulin, Lavinia, Santoro, Armando, Rigacci, Luigi, Simontacchi, Gabriele, Tani, Monica, Zaja, Francesco, Abruzzese, Elisabetta, Botto, Barbara, Zilioli, Vittorio Ruggero, Rota-Scalabrini, Delia, Freilone, Roberto, Ciccone, Giovannino, Filippi, Andrea Riccardo, Zinzani, Pier Luigi
Publicado 2021

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

por Zaccaria, Gian Maria, Ferrero, Simone, Hoster, Eva, Passera, Roberto, Evangelista, Andrea, Genuardi, Elisa, Drandi, Daniela, Ghislieri, Marco, Barbero, Daniela, Del Giudice, Ilaria, Tani, Monica, Moia, Riccardo, Volpetti, Stefano, Cabras, Maria Giuseppina, Di Renzo, Nicola, Merli, Francesco, Vallisa, Daniele, Spina, Michele, Pascarella, Anna, Latte, Giancarlo, Patti, Caterina, Fabbri, Alberto, Guarini, Attilio, Vitolo, Umberto, Hermine, Olivier, Kluin-Nelemans, Hanneke C, Cortelazzo, Sergio, Dreyling, Martin, Ladetto, Marco
Publicado 2021

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma

por Arcari, Annalisa, Rigacci, Lugi, Tucci, Alessandra, Puccini, Benedetta, Usai, Sara Veronica, Cavallo, Federica, Fabbri, Alberto, Balzarotti, Monica, Pelliccia, Sabrina, Luminari, Stefano, Pennese, Elsa, Zilioli, Vittorio Ruggero, Mahmoud, Abdurraouf Mokhtar, Musuraca, Gerardo, Marino, Dario, Sartori, Roberto, Botto, Barbara, Gini, Guido, Zanni, Manuela, Hohaus, Stefan, Tarantini, Giuseppe, Flenghi, Leonardo, Tani, Monica, Di Rocco, Alice, Merli, Michele, Vallisa, Daniele, Pagani, Chiara, Nassi, Luca, Dessì, Daniela, Ferrero, Simone, Cencini, Emanuele, Bernuzzi, Patrizia, Mammi, Caterina, Marcheselli, Luigi, Tabanelli, Valentina, Spina, Michele, Merli, Francesco
Publicado 2023

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW...

por Munir, Talha, Shadman, Mazyar, Robak, Tadeusz, R. Brown, Jennifer, Kahl, Brad, Ghia, Paolo, Giannopoulos, Krzysztof, Simkovic, Martin, Österberg, Anders, Laurenti, Luca, Walker, Patricia, Opat, Stephen, Ciepluch, Hanna, Greil, Richard, Hanna, Merit, Tani, Monica, Trneny, Marek, M. Brander, Danielle, W. Flinn, Ian, Grosicki, Sebastian, Verner, Emma, Tedeschi, Alessandra, De Guibert, Sophie, Tumyan, Gayane, Laribi, Kamel, Antonio Garcia Marco, Jose, LI, Jianyong, Tian, Tian, Ramakrishnan, Vanitha, Liu, Yu, Szeto, Andy, Paik, Jason, Cohen, Aileen, Tam, Constantine, Jurczak, Wojciech
Publicado 2023

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

por Broccoli, Alessandro, Pellegrini, Cinzia, Di Rocco, Alice, Puccini, Benedetta, Patti, Caterina, Gini, Guido, Mannina, Donato, Tani, Monica, Rusconi, Chiara, Romano, Alessandra, Vanazzi, Anna, Botto, Barbara, Carlo-Stella, Carmelo, Hohaus, Stefan, Musto, Pellegrino, Mazza, Patrizio, Molica, Stefano, Corradini, Paolo, Fama, Angelo, Gaudio, Francesco, Merli, Michele, Gravetti, Angela, Gritti, Giuseppe, Arcari, Annalisa, Tosi, Patrizia, Liberati, Anna Marina, Pinto, Antonello, Pavone, Vincenzo, Gherlinzoni, Filippo, Naso, Virginia, Volpetti, Stefano, Trentin, Livio, Goldaniga, Maria Cecilia, Bonfichi, Maurizio, De Renzo, Amalia, Schiavotto, Corrado, Spina, Michele, Storti, Sergio, Carella, Angelo Michele, Stefoni, Vittorio, Argnani, Lisa, Zinzani, Pier Luigi
Publicado 2017

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma

por Pellegrini, Cinzia, Broccoli, Alessandro, Pulsoni, Alessandro, Rigacci, Luigi, Patti, Caterina, Gini, Guido, Mannina, Donato, Tani, Monica, Rusconi, Chiara, Romano, Alessandra, Vanazzi, Anna, Botto, Barbara, Santoro, Armando, Hoaus, Stefan, Rigolin, Gian Matteo, Musto, Pellegrino, Mazza, Patrizio, Molica, Stefano, Corradini, Paolo, Fama, Angelo, Gaudio, Francesco, Merli, Michele, Ronconi, Fioravante, Gritti, Giuseppe, Vallisa, Daniele, Tosi, Patrizia, Liberati, Anna Marina, Pinto, Antonello, Pavone, Vincenzo, Gherlinzoni, Filippo, Bianchi, Maria Paola, Volpetti, Stefano, Trentin, Livio, Goldaniga, Maria Cecilia, Bonfichi, Maurizio, De Renzo, Amalia, Schiavotto, Corrado, Spina, Michele, Carella, Angelo Michele, Stefoni, Vittorio, Argnani, Lisa, Zinzani, Pier Luigi
Publicado 2017